Navigation Links
GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome
Date:1/9/2009

LONDON, RESEARCH TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

The FDA had requested that the data in a single study be reformatted. In addition, GSK conducted a review of other clinical studies taking this input into account. The withdrawal was not related to the content of the filing.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.

Solzira - is a new chemical entity that is designed to improve upon the pharmacokinetics of gabapentin by taking advantage of high-capacity transport mechanisms in the gastrointestinal tract to improve absorption.

XenoPort - is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilise the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GSK. As announced today, GSK has resubmitted to the FDA an NDA for Solzira for the treatment of moderate-to-severe primary RLS. XenoPort's product candidates are also being studied for the potential treatment of gastroesophageal reflux disease, migraine headaches, neuropathic pain, spasticity related to spinal cord injury, acute back spasms and Parkinson's disease. To lea
'/>"/>

SOURCE GlaxoSmithKline; XenoPort, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDoses Electronic Dry Powder Inhaler
2. Transcept Pharmaceuticals Announces FDA Acceptance for Review of New Drug Application for Intermezzo(R)
3. OmegaGenesis Announces Angiogenesis Application Collaboration
4. t2cure Acquires Patent Family on In Vitro Potency Testing of Stem Cells for Cardiovascular Application
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. Call for Applications: The Amgen Award for Science Teaching Excellence
7. Savient Submits Biologics License Application (BLA) for pegloticase
8. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
9. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
10. Penn State gets $5M NSF grant for Nanotech Applications and Career Knowledge
11. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25 novembre 2014 /PRNewswrie/ -- Theravalues Corporation annuncia con ... europeo in occasione di Hi Europe 2014 (dal 2 ... Si tratta della curcumina con la maggiore biodisponibilità ... cristalli) e ingredienti approvati dalle norme europee. ... della pianta curcumina ( Curcuma longa ) che è ...
(Date:11/24/2014)... , Nov. 24, 2014  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA), which ... 2014 to seven, with eighteen submissions now pending at ... President and CEO of the Company, commented, "Our team ...
(Date:11/24/2014)... 2014  Last week, Representatives Gus Bilirakis ... took a bold bipartisan step on behalf of ... Act. Original co-sponsors of the legislation include Representatives ... incentivize drug makers and innovators to "repurpose" major ... cancers, which opens the door to the development ...
(Date:11/24/2014)...   First published ... Elsevier , a world-leading provider of scientific, technical ... the launch of the latest title in the Current ... Food Science . Current ... new platform to keep up-to-date with the expanding volume of ...
Breaking Biology Technology:La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3IGI Laboratories, Inc. Announces ANDA Submission 2OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... University of California, Berkeley, have developed a pressure-sensitive electronic ... new meaning to the term "thin-skinned." "The ... the human skin, which means incorporating the ability to ... of electrical engineering and computer sciences and head of ...
... Spotlights Innovations During ESTRO29 -- VEENENDAAL, The Netherlands, September 10, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... lure of greater profits elsewhere in the world may ... and distribution of affordable drugs, vaccines and diagnostics for ... millions of poor people, experts warn. And they ... support for continuing the success of firms finding homegrown ...
Cached Biology Technology:Engineers make artificial skin out of nanowires 2Engineers make artificial skin out of nanowires 3Nucletron Spotlights Innovations During ESTRO29 2Nucletron Spotlights Innovations During ESTRO29 3Nucletron Spotlights Innovations During ESTRO29 4Nucletron Spotlights Innovations During ESTRO29 5Nucletron Spotlights Innovations During ESTRO29 6Nucletron Spotlights Innovations During ESTRO29 7Global health vs. global wealth: Looming choice for health firms in developing countries 2Global health vs. global wealth: Looming choice for health firms in developing countries 3Global health vs. global wealth: Looming choice for health firms in developing countries 4
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... Scientists at Joslin Diabetes Center have identified biological mechanisms ... against kidney disease, and also mechanisms that inhibit its ... online by Diabetes, may lead to the development of ... to prevent the harmful effects of hyperglycemia on renal ...
... melanoma is a malignant form of skin cancer and ... there is. Treatment is particularly difficult, because melanomas are ... Chris Marine, (VIB/KU Leuven) have found a new line ... cancers, namely by combating the interaction between the protein ...
... observes a colorful jellyfish pulsating through the ocean, Greek ... animal once was known as the medusa, after the ... gaze turned people into stone, and now, thanks to ... researchers at the California Institute of Technology (Caltech) and ...
Cached Biology News:Joslin researchers gain new understanding of diabetes and kidney disease 2Joslin researchers gain new understanding of diabetes and kidney disease 3New line of approach for combination therapy against melanoma 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 3Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 4
Request Info...
Purified anti-eIF-4E...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Purified anti-PXR...
Biology Products: